Cited by Lung Transplant From Coronavirus Disease 2019–Positive Donors: Cautiously Optimistic

ORCHESTRA Delphi Consensus: Diagnostic and Therapeutic Management of SARS-CoV-2 Infection in Solid Organ Transplant Recipients DOI

Beatrice Tazza,

Natascia Caroccia,

Alice Toschi

et al.

Clinical Microbiology and Infection, Journal Year: 2025, Volume and Issue: unknown

Published: Feb. 1, 2025

Language: Английский

Citations

Non-Standard Risk Donors and Risk of Donor-Derived Infections: From Evaluation to Therapeutic Management DOI

Paolo Grossi, Cameron R. Wolfe, Maddalena Peghin

et al.

Transplant International, Journal Year: 2024, Volume and Issue: 37

Published: Oct. 2, 2024

Expected and unexpected donor-derived infections are a rare complication of solid organ transplantation, but can result in significant morbidity mortality. Over the last years, growing gap existing between patients on waiting list available organs has favored use from donors with suspected or confirmed infections, thanks to improvement risk mitigation strategies against transmission well recognized emerging infections. Given recent developments, particular interest this review is summarize data how maximize utilization HIV+ recipients, HCV-viremic HBV positive donors. This article also covers implications for recipient bacteremia challenge multidrug resistant (MDR) Lastly describes risks associated Coronavirus Disease-2019 (COVID-19) pandemics.

Language: Английский

Citations

A role for extensive SARS‐CoV‐2 virological assessment of donor and recipient in lung transplantation DOI

Jan Van Slambrouck, Katrien Lagrou, Laurens J. Ceulemans

et al.

Transplant Infectious Disease, Journal Year: 2024, Volume and Issue: 26(5)

Published: July 22, 2024

Language: Английский

Citations

Acceptance of Organs from Deceased Donors With Resolved or Active SARS-CoV-2 Infection: A Survey From the Council of Europe DOI

Maddalena Peghin,

Elena Graziano, Maria De Martino

et al.

Transplant International, Journal Year: 2024, Volume and Issue: 37

Published: Nov. 21, 2024

SARS-CoV-2 infection represents a new challenge for solid organ transplantation (SOT) with evolving recommendations. A cross-sectional survey was performed (February-June 2024) to describe practices among Member States of the Council Europe (COE) on use organs from deceased donors resolved or active infection. Overall, 32 out 47 transplant program participated in study. Four (12.5%) countries did not either and 8 (25%) accepted only Donor evaluation included universal screening standard PCR testing respiratory specimens generally (61.4%) within 24 h prior recovery. Further microbiological, immunological radiological investigations varied. Most waitlisted patients receiving donor (94.5%) (61.5%) were preferred have natural, vaccine-induced hybrid immunity. require recipients undergo specific anti-SARS-CoV-2 treatment as pre-exposure (0%), post-exposure prophylaxis (15.4%) modification immunosuppression regimen (24%). This study highlights similarities heterogeneities management positive between COE countries, potential safely expand donors' pool.

Language: Английский

Citations

Short-Term Outcomes Among Lung Transplant Recipients from SARS-CoV-2+ Donors and Evaluation of Lung Function Among SARS-CoV-2+ Donors DOI

Toyokazu Endo, Jaimin R. Trivedi, Erin M. Schumer

et al.

Transplantation Proceedings, Journal Year: 2024, Volume and Issue: unknown

Published: Nov. 1, 2024

Language: Английский

Citations

Lung Transplant From Coronavirus Disease 2019–Positive Donors: Cautiously Optimistic DOI

Lorenzo Zaffiri, Cameron R. Wolfe

The Annals of Thoracic Surgery, Journal Year: 2023, Volume and Issue: 116(5), P. 1054 - 1055

Published: Aug. 1, 2023

Language: Английский

Citations